We are fortunate to advise world-class, industry-leading companies, helping them tackle novel, complex issues and push the boundaries of technological progress. Our ability and confidence to go to trial is our core strength; our deep bench of experienced trial lawyers represents companies in their most significant matters, helping them protect their intellectual property and launch products. Our lawyers pair extensive experience in the courtroom and the boardroom with a thorough understanding of science and technology.
Awards & Recognition
Paul, Weiss Shortlisted in Three Categories for LMG Life Sciences Americas Awards
Paul, Weiss is shortlisted in three categories in LMG Life Sciences’ 2022 LMG Life Sciences Americas Awards. The firm is a contender for “General Patent Litigation Firm of the Year.”
» moreClient News
Genentech Wins Summary Judgment in Patent Dispute Over Hemophilia A Drug
See Also
Paul, Weiss won a major victory on behalf of Genentech in patent litigation brought by Baxalta, Inc. and Baxalta GmbH (now subsidiaries of Takeda Pharmaceuticals) concerning Genentech’s breakthrough hemophilia treatment HEMLIBRA® (emicizumab).
» morePublications
Intellectual Property Litigation: Distinguishing Unexpected Results In Evaluating Non-Obviousness
Litigation partners Catherine Nyarady and Crystal Parker’s latest Intellectual Property Litigation column, “Distinguishing Unexpected Results In Evaluating Non-Obviousness,” appeared in the July 12 issue of the New York Law Journal.
» moreAwards & Recognition
Paul, Weiss Life Sciences Practice Named Law360 “Practice Group of the Year”
Paul, Weiss won Law360 “Practice Group of the Year” recognition for its achievements in 2021 in the Life Sciences category.
» moreClient News
Edwards Lifesciences Wins Court Victory in Patent Dispute Over Heart Valve Repair Device
See Also
Paul, Weiss won a significant victory for Edwards Lifesciences in patent litigation brought by Abbott Laboratories concerning Edwards’ PASCAL, an important new medical device recently approved for use in Europe to treat a common form of often-fatal heart disease called mitral regurgitation.
» more